Beta amyloid vaccines data

Researchers from two groups separately published in Nature that beta amyloid peptide vaccines reduce neurological deficits in mouse models of AD. Toronto researchers and colleagues demonstrated that beta amyloid peptide immunization reduced fibrillar beta amyloid deposition and cognitive dysfunction without altering total brain levels of beta amyloid, and Florida researchers and colleagues showed that 8 months of beta amyloid vaccination protected a different transgenic mouse model of AD from learning and age-related memory deficits. ...